Notable Thursday Option Activity: AAPL, RKLB, CRSP

Rocket Lab Corp (RKLB) and CRISPR Therapeutics AG (CRSP) both experienced exceptionally high options trading volumes, with RKLB's options volume representing 99.2% of its average daily share volume and CRSP's at 98.9%. Notably, specific long-dated call options, including the $53 strike for RKLB expiring October 2025 and the $80 strike for CRSP expiring November 2025, saw significant trading activity, indicating heightened speculative interest or a bullish outlook among options traders for these equities.

Analysis

Rocket Lab Corp (RKLB) and CRISPR Therapeutics AG (CRSP) have both registered exceptional options trading activity, with total options volume equating to 99.2% and 98.9% of their respective average daily share volumes. This indicates a significant shift of trading interest into the derivatives market for these equities. The activity is not diffuse; it is highly concentrated in specific long-dated call options. For RKLB, a notable 16,379 contracts were traded for the $53 strike call expiring in October 2025. Similarly, CRSP saw significant interest in its $80 strike call expiring in November 2025, with 3,234 contracts traded. The focus on call options with expiration dates more than a year away suggests that this is not short-term speculative noise but rather strategic positioning by market participants anticipating substantial price appreciation in both companies over a multi-year horizon.

Key Decisions for Investors

• Investors with an existing or potential long position in RKLB or CRSP may view this concentrated, long-dated call buying as a reinforcing signal for a multi-year bullish thesis.